Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone health and aging: implications for menopause.

Faryal S Mirza1, Karen M Prestwood

  • 1Department of Medicine, University of Connecticut Health Center, Farmington, CT 06030, USA.

Endocrinology and Metabolism Clinics of North America
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Challenging Case of Diabetes in a Patient With XXYY Syndrome.

JCEM case reports·2024
Same author

A Sweet Paradox: Severe Insulin Resistance and Hyperglycemia in Asymptomatic COVID-19 Infection.

Cureus·2023
Same author

Giant Prolactinoma Presenting With Facial Nerve Palsy and Hemiparesis.

Journal of the Endocrine Society·2021
Same author

PROINSULIN-PREDOMINANT PANCREATIC NEUROENDOCRINE TUMOR-INDUCED HYPOGLYCEMIA AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY.

AACE clinical case reports·2020
Same author

Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.

Nutrition research (New York, N.Y.)·2013
Same author

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

The Journal of clinical endocrinology and metabolism·2010
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Low-dose estrogen may benefit postmenopausal women by promoting bone health and reducing osteoporosis risks. This approach may outweigh potential risks for select women experiencing menopausal symptoms.

Area of Science:

  • Reproductive Endocrinology
  • Bone Metabolism
  • Geriatric Health

Background:

  • Osteoporosis is a significant health concern for postmenopausal women, increasing morbidity and mortality.
  • Hormone therapy (HT) was previously used for menopausal symptoms and osteoporosis prevention, but recent evidence highlights associated health risks.
  • The current role of HT for menopausal women is debated, though it remains important for symptom management.

Purpose of the Study:

  • To review the use of low-dose estrogen for improving bone health in postmenopausal women.
  • To explore the potential benefits of low-dose estrogen in mitigating osteoporosis risks.
  • To assess the risk-benefit profile of estrogen therapy in specific postmenopausal populations.

Main Methods:

  • Review of existing literature on estrogen therapy and bone health in postmenopausal women.

Related Experiment Videos

  • Analysis of studies investigating low-dose estrogen effects on menopausal symptoms and bone density.
  • Evaluation of the comparative risks and benefits of hormone therapy for osteoporosis prevention.

    • Main Results:

    • Evidence suggests that estrogen therapy can protect against osteoporosis, particularly hip fractures.
    • Lower-than-usual doses of estrogen have demonstrated efficacy in reducing menopausal symptoms and preserving bone.
    • The benefits of HT for bone health may outweigh the risks in a carefully selected group of women.

    Conclusions:

    • Low-dose estrogen therapy presents a potential strategy for promoting bone health in postmenopausal women.
    • Further research is needed to fully understand the optimal use of HT for bone protection and symptom management.
    • Careful patient selection is crucial when considering hormone therapy for postmenopausal women with osteoporosis concerns.